iSpecimen Inc. operates a sophisticated technological platform that effectively bridges the gap between life science researchers and crucial human biological materials. Its proprietary cloud-based system empowers scientists to efficiently locate and access a vast array of biospecimens—such as biofluids, tissues, and living cells—as well as connect with potential study subjects, all sourced from a global network of healthcare providers, including hospitals, laboratories, biobanks, and blood centers. The company develops and manages iSpecimen Marketplace, an innovative online hub that strategically links medical researchers requiring access to subjects, samples, and pertinent data with organizations that hold these invaluable resources. iSpecimen's clientele primarily includes biopharmaceutical firms, in vitro diagnostics companies, and governmental and academic research institutions. The company, established in 2009, is headquartered in Lexington, Massachusetts.
iSpecimen Inc. Announces Closing of $5 Million Public Offering of Common Stock and Pre-Funded Warrants
iSpecimen Inc. closed a $5.0 million public offering, consisting of 996,231 shares of common stock and pre-funded warrants to purchase 2,849,923 shares.
The company plans to use the net proceeds to repay outstanding liabilities, fund potential acquisitions or investments, and support marketing and working capital needs.
E.F. Hutton & Co. acted as the exclusive placement agent for the offering, which was conducted pursuant to an effective registration statement on Form S-1.